Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Akero Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +12 vs. Q1 2022
- Shares held
- 36.7M
- +1.57M (+4.5%) vs. Q1 2022
- Total value
- $329.6M
- −$169.0M (−33.9%) vs. Q1 2022
- New holders
- 22
- 40 more added
- Sold out
- 10
- 29 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 831,495 | $7.86M | 0.50% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,005,682 | $9.50M | 0.02% | +1,005,682 | New |
| Vanguard Group Inc | 1,311,014 | $12.4M | 0.00% | +84,103+6.9% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,359,052 | $12.8M | 0.28% | −1000.0% | Reduced |
| Redmile Group, LLC | 1,587,285 | $15.0M | 0.57% | −15,000−0.9% | Reduced |
| Yiheng Capital Management, L.P. | 1,882,698 | $17.8M | 1.27% | +329,708+21.2% | Added |
| BlackRock Inc. | 2,091,241 | $19.8M | 0.00% | +195,713+10.3% | Added |
| venBio Partners LLC | 2,171,664 | $20.5M | 5.84% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,232,251 | $21.1M | 3.53% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,300,000 | $21.7M | 0.10% | +453,000+24.5% | Added |
| Alkeon Capital Management LLC | 2,619,671 | $24.8M | 0.15% | +200,000+8.3% | Added |
| Janus Henderson Group PLC | 3,068,312 | $29.0M | 0.02% | −300,350−8.9% | Reduced |
| Skorpios Trust | 4,907,829 | $46.4M | 19.41% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 0 | $0 | 0.00% | −617,727−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −67,455−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −27,553−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,585−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −628−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |